10-K Decoder · All companies

Starling Oncology, Inc.

STLN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$503M$393M+27.8%
Operating income−$36.1M−$60.1M+40.0%
Net income−$50.3M−$53.0M+5.1%

Questions

What was Starling Oncology's revenue in FY2025?
$503M in FY2025 (Fiscal year ended Dec 31, 2025), +27.8% vs $393M a year earlier, per its 10-K filed Mar 2026.
Was Starling Oncology profitable in FY2025?
No: net income was −$50.3M and operating income −$36.1M in FY2025.